Client teaching regarding the use of leukotriene receptor antagonist (LTRAS) drug such as Montelukast (Singulair) would include which statement by the nurse?

Montelukast is typically prescribed as a once-daily medication for the treatment of asthma. Taking it in the evening can be beneficial as it helps to control asthma symptoms throughout the day and night. It is important to follow the prescribed dosing schedule provided by the healthcare provider.

The other statements mentioned are incorrect:
A. "I'll rinse my mouth after taking this medication": Rinsing the mouth after taking montelukast is not necessary as it is not an inhaled medication. Rinsing the mouth is typically recommended after using inhaled corticosteroids to reduce the risk of oral thrush.

B. "I'll take this medication when I get an asthma attack": Montelukast is a long-term control medication used to prevent asthma attacks and manage chronic asthma symptoms. It is not intended for immediate relief during an asthma attack.

C. "I use a spacer device when I inhale this medication": Montelukast is not an inhaled medication, so the use of a spacer device is not applicable. Spacer devices are commonly used with inhaled medications to improve the delivery of the medication to the lungs.

The nurse will tell the patient that second-generation antihistamines are generally considered safer than first-generation antihistamines during pregnancy. While the safety of medications during pregnancy is a complex topic and individualized recommendations should be obtained from a healthcare provider, second-generation antihistamines such as loratadine (Claritin) and cetirizine (Zyrtec) are often preferred over first-generation antihistamines like diphenhydramine (Benadryl) due to their lower potential for sedation and other side effects. However, it is still important for the patient to consult with her healthcare provider for personalized advice on medication use during pregnancy.